Letter: the safety of herpes zoster vaccination for patients with inflammatory bowel disease being treated with anti‐TNF medications

Letter: the safety of herpes zoster vaccination for patients with inflammatory bowel disease being treated with anti‐TNF medications

Linked Content This article is linked to Khan et al and Khan and Lewis papers. To view these articles visit https://doi.org/10.1111/apt.14257 and https://doi.org/10.1111/apt.14460.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2018-02, Vol.47 (3), p.446-447
Hauptverfasser: Côté‐Daigneault, J., Luong, M.L., Colombel, J.‐F., Peerani, F.
Format: Artikel
Sprache:eng
Schlagworte:
Herpes Zoster
Humans
Inflammatory Bowel Diseases
Intestine
Tumor necrosis factor
Tumor Necrosis Factor-alpha
Vaccination
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Linked Content This article is linked to Khan et al and Khan and Lewis papers. To view these articles visit https://doi.org/10.1111/apt.14257 and https://doi.org/10.1111/apt.14460.
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.14435